Signaturefd, LLC Karyopharm Therapeutics Inc. Transaction History

Signaturefd, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$4.08 - $5.82 $1,664 - $2,374	408 Added 205.03%	607 $3,000
Q2 2022 Aug 10, 2022	SELL	$4.15 - $8.37 $3,639 - $7,340	-877 Reduced 81.51%	199 $1,000
Q1 2022 May 02, 2022	SELL	$5.91 - $14.38 $4,089 - $9,950	-692 Reduced 39.14%	1,076 $8,000
Q4 2021 Jan 25, 2022	SELL	$5.21 - $8.61 $672 - $1,110	-129 Reduced 6.8%	1,768 $11,000
Q3 2021 Oct 28, 2021	BUY	$4.45 - $10.63 $1,539 - $3,677	346 Added 22.31%	1,897 $11,000
Q2 2021 Jul 26, 2021	BUY	$8.11 - $11.11 $786 - $1,077	97 Added 6.67%	1,551 $16,000
Q1 2021 Apr 30, 2021	BUY	$9.85 - $17.69 $3,486 - $6,262	354 Added 32.18%	1,454 $15,000
Q4 2020 Feb 11, 2021	BUY	$14.15 - $17.19 $13,201 - $16,038	933 Added 558.68%	1,100 $17,000
Q3 2020 Nov 03, 2020	SELL	$14.14 - $19.71 $1,569 - $2,187	-111 Reduced 39.93%	167 $2,000
Q2 2020 Jul 30, 2020	BUY	$16.6 - $25.25 $1,660 - $2,525	100 Added 56.18%	278 $5,000
Q1 2020 Apr 23, 2020	SELL	$14.38 - $27.72 $1,207 - $2,328	-84 Reduced 32.06%	178 $3,000
Q4 2019 Feb 05, 2020	BUY	$9.23 - $19.67 $2,418 - $5,153	262 New	262 $5,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $53.5M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.